PGR and neoplasm: Low Ki67 expression was associated with pT1, luminal A, ER- and PR-positive, invasive lobular carcinoma and grade II tumours, while high Ki67 expression was associated with pT2, luminal B, HER2-, ER- and PR-negative (triple-negative), invasive ductal carcinoma and grade III tumours (P < 0.05).